Cancer Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Oct 2020| TMR2184A| Transparency

Report Highlights

Global Cancer Diagnostics Market - Scope of Report

TMR’s report on the global cancer diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cancer diagnostics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cancer diagnostics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cancer diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cancer diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cancer diagnostics market.

The report delves into the competitive landscape of the global cancer diagnostics market. Key players operating in the global cancer diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cancer diagnostics market that have been profiled in this report.

Key Questions Answered in Global Cancer Diagnostics Market Report

  • What is the scope of growth of product companies in the global cancer diagnostics market?
  • What will be the Y-o-Y growth of the global cancer diagnostics market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global cancer diagnostics market?
  • Will North America continue to be the most profitable market for cancer diagnostics providers?
  • Which factors are anticipated to hamper the growth of the global cancer diagnostics market during the forecast period?
  • Which are the leading companies in the global cancer diagnostics market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global cancer diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global cancer diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the cancer diagnostics market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cancer diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cancer diagnostics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global cancer diagnostics market more reliably and accurately.

  • Table 1 : List of Abbreviation
  • Table 2 : Market Snapshot Global Cancer Diagnostics Market
  • Table 3 : List of Cancer Risk Factors
  • Table 4 : Estimated Incidence, 1 year, 2 years and 5 years survival
  • Table 5 : Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
  • Table 6 : Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
  • Table 7 : Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
  • Table 8 : Summary of Type of Diagnostics Test in the U.S.
  • Table 9 : Event Impact Analysis Global Cancer Diagnostics Market, 2017-2027
  • Table 10 : Global Cancer Diagnostics Market Revenue, by Method, 2017-2027 (USD) Million
  • Table 11 : Global Cancer Diagnostics Market Revenue, by Application, 2017-2027 (USD) Million
  • Table 12 : Global Cancer Diagnostics Market Revenue, by Geography, 2017-2027 (USD) Million
  • Figure 1 : Global Cancer Diagnostics Market Segmentation
  • Figure 2 : Global Cancer Diagnostics Market, by Application, 2018 (USD Million)
  • Figure 3 : Comparative Analysis
  • Figure 4 : Porter’s Five Forces Analysis Global Cancer Diagnostics Market, by Geography, 2018 & 2027E (Value %)
  • Figure 5 : Market Attractiveness Analysis Global Cancer Diagnostics Market
  • Figure 6 : Cancer Diagnostics Market Global Cancer Diagnostics Market, By Method, 2018 & 2027 (Value %)
  • Figure 7 : Cancer Diagnostics Market Global Market Share by Key Players, IVDs, Molecular Diagnostics and Companion Diagnostics), 2018 (Value %)
  • Figure 8 : Global Prostate Specific Antigen Tests Market Revenue, 2017-2027 (USD Million) Global Market Share by Key Players, 2018 (Value %)
  • Figure 9 : Global Circulating Tumor Cells (CTC) Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 10 : Global Alpha-Fetoprotein (AFP) Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 11 : Global CA 19-9 Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 12 : Global CA-125 Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 13 : Global EGFR Mutation Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 14 : Global HER2 Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 15 : Global Carcinoembryonic Antigen (CEA) Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 16 : Global BRCA Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 17 : Global KRAS Mutation Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 18 : Global Anaplastic Lymphoma Kinase (ALK) Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 19 : MRI Scan Cancer Diagnosis Market Revenue, 2017-2027 (USD Million)
  • Figure 20 : PET Scan Cancer Diagnosis Market Revenue, 2017-2027 (USD Million)
  • Figure 21 : CT Scan Cancer Diagnosis Market Revenue, 2017-2027 (USD Million)
  • Figure 22 : Mammography Cancer Diagnosis Market Revenue, 2017-2027 (USD Million)
  • Figure 23 : Ultrasound Cancer Diagnosis Market Revenue, 2017-2027 (USD Million)
  • Figure 24 : Global Colonoscopy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 25 : Global Sigmoidoscopy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 26 : Global Bronchoscopy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 27 : Global Colposcopy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 28 : Global Other Endoscopy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 29 : Global Bone Marrow Biopsy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 30 : Global Needle Biopsy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 31 : Global Endoscopic Biopsy Tests Market Revenue, 2017-2027 (USD Million)
  • Figure 32 : Comparative analysis
  • Figure 33 : Blood Cancer Global Cancer Diagnostics Market, by Applications, 2018 & 2027 (Value %)
  • Figure 34 : Global Blood Cancer Diagnostics Market Revenue, 2017-2027 (USD Million) Estimated number of new cases, all ages, both sexes (2012, 2015 & 2027)
  • Figure 35 : Comparative Analysis
  • Figure 36 : North America Cancer Diagnostics Market Revenue, 2017-2027 (USD Million) Global Cancer Diagnostics Market, By Geography, 2018 & 2027 (Value %)
  • Figure 37 : Europe Cancer Diagnostics Market Revenue, 2017-2027 (USD Million)
  • Figure 38 : Asia Pacific Cancer Diagnostics Market Revenue, 2017-2027 (USD Million)
  • Figure 39 : Rest of the World Cancer Diagnostics Market Revenue, 2017-2027 (USD Million)
  • Figure 40 : Abbott Laboratories
  • Figure 41 : Astra Zeneca plc Annual Revenue, (USD Million)
  • Figure 42 : bioMeriux SA Annual Revenue, (USD Million)
  • Figure 43 : Eli Lilly and Company Annual Revenue, (USD Million)
  • Figure 44 : GlaxoSmithKline plc Annual Revenue, (USD Million)
  • Figure 45 : F Annual Revenue, (USD Million)
  • Figure 46 : Pfizer, Inc Annual Revenue, (USD Million)
  • Figure 47 : Annual Revenue, (USD Million)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report